title: Induction of microsomal triglyceride transfer protein expression is a candidate mechanism by which ezetimibe therapy might exert beneficial effects in patients with nonalcoholic steatohepatitis.
authors.forename: Masato
authors.initials: M
authors.lastname: Yoneda
authors.forename: Koji
authors.initials: K
authors.lastname: Fujita
authors.forename: Kento
authors.initials: K
authors.lastname: Imajo
authors.forename: Hironori
authors.initials: H
authors.lastname: Mawatari
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Kirikoshi
authors.forename: Satoru
authors.initials: S
authors.lastname: Saito
authors.forename: Atsushi
authors.initials: A
authors.lastname: Nakajima
mesh_terms: D000924:Anticholesteremic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001384:Azetidines / Q000494:pharmacology* / Q000627:therapeutic use; D002352:Carrier Proteins / Q000378:metabolism*; D000069438:Ezetimibe; D005234:Fatty Liver / Q000188:drug therapy / Q000378:metabolism; D006801:Humans; D065626:Non-alcoholic Fatty Liver Disease
chemical_list: D000924:Anticholesteremic Agents; D001384:Azetidines; D002352:Carrier Proteins; C106092:microsomal triglyceride transfer protein; D000069438:Ezetimibe